NEW YORK (TheStreet) -- Welcome to Don Dion's Daily ETF Winners and Losers. Be sure to stop by each day to get a feel of who's winning and who's losing when it comes to ETFs.

Winners

iPath Dow Jones UBS Sugar Total Return Subindex ETN

(SGG) - Get Report

2.9%

TST Recommends

Sugar prices are ramping higher today, continuing along its near unstoppable upward trajectory. SGG, which is designed to track the performance of sugar futures contracts has seen impressive performance throughout 2010, tumbling to revisit all-time lows during the start of the year and now testing new all time highs this week.

ETFS Physical Palladium Shares

(PALL) - Get Report

2.8%

Precious metals are powering upward today, lifting physically based funds such as PALL and miner backed products such as

Market Vectors Junior Gold Miners ETF

(GDXJ) - Get Report

to nice gains.

GDXJ's gains today put an end to a four-day decline. Gold remains an attractive investment opportunity for those seeking protection against market volatility.

iShares MSCI Italy Index Fund

(EWI) - Get Report

2.8%

Strength from the euro is helping to lift some of the most volatile E.U. nations today. Italy is leading the way, though strength can also be seen from the

iShares MSCI Spain Index Fund

(EWP) - Get Report

.

Although riots aided to

iShares MSCI France Index Fund

's

(EWQ) - Get Report

weakness on Tuesday, it is doing little to stifle its performance on Wednesday. The fund is up 2.6%.

Losers

iPath S&P 500 VIX Short Term Futures ETN

(VXX) - Get Report

-3.9%

The VIX-based VXX has volleyed back and forth quite a bit over the past few days. However, the fund appears to be stuck in a downward path. VXX continues to carve out new all-time lows despite the resilient uncertainty in today's market. It is not worth toying with this fund; there is no telling how far it will go.

SPDR S&P Biotech ETF

(XBI) - Get Report

-1.6%

Biotechnology is weak today with XBI and

First Trust Amex Biotechnology Index Fund

(FBT) - Get Report

carving out heavy losses. Leading this industry lower is Amylin Pharmaceuticals, which is off over 40% in early afternoon trading.

This type of hit-or-miss nature inherent of the biotech industry is exciting to watch but can make it tricky for stock pickers to navigate. The index strategy employed by ETFs can make the swings less gut-wrenching.

Market Vectors Vietnam ETF

(VNM) - Get Report

-0.6%

Although emerging and frontier markets remain attractive destinations for investors looking for opportunities outside of the developed economies of the United States and European Union, they remain volatile regions of the globe. Therefore, investors should expect notable day-to-day swings such as the one seen today from VNM.

All prices as of 2:15 PM EST

Written by Don Dion in Williamstown, Mass.

At the time of publication, Dion Money Management did not have a position in any of the funds mentioned.

Don Dion is president and founder of

Dion Money Management

, a fee-based investment advisory firm to affluent individuals, families and nonprofit organizations, where he is responsible for setting investment policy, creating custom portfolios and overseeing the performance of client accounts. Founded in 1996 and based in Williamstown, Mass., Dion Money Management manages assets for clients in 49 states and 11 countries. Dion is a licensed attorney in Massachusetts and Maine and has more than 25 years' experience working in the financial markets, having founded and run two publicly traded companies before establishing Dion Money Management.

Dion also is publisher of the Fidelity Independent Adviser family of newsletters, which provides to a broad range of investors his commentary on the financial markets, with a specific emphasis on mutual funds and exchange-traded funds. With more than 100,000 subscribers in the U.S. and 29 other countries, Fidelity Independent Adviser publishes six monthly newsletters and three weekly newsletters. Its flagship publication, Fidelity Independent Adviser, has been published monthly for 11 years and reaches 40,000 subscribers.